ML329 significantly inhibits MITF activity in GIST, as measured using a reporter gene assay, Melastatin 1 (TRPM-1) promoter-controlled firefly luciferase (Figures 1C and 1I). The gene discussed is TRPM1; the disease is gastrointestinal stromal tumor.